Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000513313 | SCV000609203 | likely benign | not provided | 2023-07-01 | criteria provided, single submitter | clinical testing | SYNGAP1: PP2, BP4, BS2 |
Ambry Genetics | RCV002311827 | SCV000846336 | likely benign | Inborn genetic diseases | 2021-08-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV000764648 | SCV000895757 | uncertain significance | Intellectual disability, autosomal dominant 5 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000764648 | SCV000940717 | benign | Intellectual disability, autosomal dominant 5 | 2024-12-02 | criteria provided, single submitter | clinical testing |